Logo Logo
Switch Language to German
Zitzmann, K.; de Toni, E.; Ruden, J. von; Brand, S.; Göke, Burkhard; Laubender, Rüdiger P.; Auernhammer, C. J. (2011): The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells. In: Endocrine-Related Cancer, Vol. 18, No. 2: pp. 277-285
Full text not available from 'Open Access LMU'.